7 research outputs found

    Criteria for feasibility, health and welfare assessment of requirement to use second and subsequent generations of non-human primates or animals from self-sustaining colonies in research CritĂšres d’évaluation de la faisabilitĂ©, de l’incidence sanitaire et des rĂ©percussions sur le bien-ĂȘtre animal, relatifs Ă  l'obligation future d'utiliser des primates non humains issus uniquement des animaux de deuxiĂšme gĂ©nĂ©ration et plus ou des animaux provenant de colonies d'Ă©levage auto-entretenues pour la recherche expĂ©rimentale

    No full text
    The European Directive 2010/63/EU on the protection of animals used for scientific purposes requires that a feasibility study must be conducted by the European Commission to determine if all sourcing of non-human primates from parents bred in captivity (F2) or from self-sustaining colonies can be achieved. This study should also include an assessment of animal health and welfare. Prior to the initiation of the European Commission’s study, it was considered by EFPIA and FELASA that the criteria to be used in the feasibility, health and welfare assessment should be established by experts to help expedite such a study. This paper identifies those criteria which may be useful in making policy decisions on the confirmation or reconsideration of the timetable for implementation of the F2 requirement. A key requirement before a number of criteria can be assessed is the generation of base-line data relating to the supply and future demand of non-human primates and the health and welfare status of current breeding colonies supplying the European market. Three groups of criteria have been indentified, namely feasibility, science and research and welfare. Within each group, a number of parameters are defined and their rationale for inclusion, together with suggested information points, is discussed.<br>La directive europĂ©enne 2010/63/EU sur la protection des animaux utilisĂ©s Ă  des fins scientifiques exige qu'une Ă©tude de faisabilitĂ© soit conduite par la Commission europĂ©enne afin de dĂ©terminer si l’approvisionnement en primates non-humains Ă  partir de gĂ©niteurs Ă©levĂ©s en captivitĂ© (F2) ou de colonies d'Ă©levage autosuffisantes, peut ĂȘtre possible. Cette Ă©tude devra Ă©galement inclure une Ă©valuation de la santĂ© des animaux et de leur bien-ĂȘtre. Avant le dĂ©but de cette Ă©tude par la Commission europĂ©enne, l'EFPIA et FELASA ont estimĂ© que les critĂšres Ă  utiliser pour les Ă©valuations de la faisabilitĂ©, de la santĂ© des animaux et du bien-ĂȘtre animal devraient ĂȘtre dĂ©finis rigoureusement par des experts pour faciliter et accĂ©lĂ©rer le travail de la Commission europĂ©enne. Cet article identifie les critĂšres qui peuvent ĂȘtre utiles dans la prise de dĂ©cisions politiques sur la confirmation de l’exigence de la directive ou sur le rĂ©examen de l'Ă©chĂ©ancier de mise en Ɠuvre de l'exigence d'utiliser dans le futur uniquement des primates non-humains de gĂ©nĂ©rations F2. Un Ă©lĂ©ment clĂ© avant qu'un certain nombre de critĂšres puissent ĂȘtre Ă©valuĂ©s est la dĂ©termination de donnĂ©es de base relatives Ă  l'offre et la demande de primates non humains, Ă  leur Ă©tat sanitaire et leur Ă©tat de bien-ĂȘtre dans les colonies de reproduction destinĂ©es Ă  approvisionner le marchĂ© europĂ©en. Trois grandes catĂ©gories ont Ă©tĂ© identifiĂ©es, Ă  savoir la faisabilitĂ© de gĂ©rer ces colonies d'Ă©levage, leur incidence sur la recherche scientifique et la garantie du bien-ĂȘtre animal. Pour chaque catĂ©gorie, un certain nombre de paramĂštres sont dĂ©finis et justifiĂ©s, avec des Ă©lĂ©ments d'information suggĂ©rĂ©s et discutĂ©s

    Consensus Recommendations for the Use of Simulation in Therapeutic Patient Education.

    Full text link
    peer reviewedINTRODUCTION: Simulation is rarely used to help individuals with chronic diseases develop skills. The aim of the study was to provide recommendations for the use of simulation in therapeutic patient education (S-TPE). METHODS: Expert consensus was achieved with the participation of the following 3 groups of experts: (a) expert patients and caregivers; (b) health professionals specialized in therapeutic patient education (TPE); and (c) simulation experts. Each expert received a list of questions by e-mail in 3 iterations. The synthesis of the 2 first questionnaires resulted in 34 first recommendations voted during the consensus conference meeting. Each recommendation was subject to an extensive literature review. The quality of the evidence and the strength of the recommendations were assessed through the evaluation, development, and evaluation criteria categories (GRADE criteria). The third questionnaire selected and illustrated recommendations more specific to the use of S-TPE. RESULTS: At the end of the process, the experts identified 26 recommendations specific to the use of S-TPE. They proposed examples of skills in different diseases and stressed the importance of adapting the conditions of use (location, equipment, time of the care) to the circumstances of the patient learner and skills to be developed. Experts should exercise great caution as this technique presents ethical considerations related to patient care. CONCLUSIONS: These recommendations underline the fact that simulation could bring added value to TPE. They provide a framework and examples for the experimental use of simulation in TPE. Research into feasibility and acceptability is needed
    corecore